MAPT and Alzheimer disease: It has been repeatedly reported that the overexpression of Hsp70 facilitates the degradation of α-synuclein [18], a risk factor for PD, and eliminates the hyperphosphorylated microtubule-associated protein tau (tau) [17], a primary pathological component of AD.